FDA scientists warn against expanded access to peptides as Kennedy reshuffles advisory panel
Main roads Professional scientists at the Food and Drug Administration recommend complex access to peptides against RFK Jr.’s pressure. The advisory panel, which reviews the seven peptides, includes several members with ties to clinics and peptide companies. Peptides like BPC-157…



